癌診断装置の世界市場:肺癌、乳癌、大腸癌、前立腺癌、子宮頸癌...市場調査レポートについてご紹介

【英文タイトル】Global Cancer Diagnostics Device Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Cancer statistics

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Reimbursement and coverage: An overview
• Current scenario: Validating diagnostic tests
• Reimbursement structure in US
• Reimbursement structure in EU

PART 08: Cancer diagnostic devices: Pricing scenario

PART 09: Market segmentation by product
• Global companion cancer diagnostic devices market
• Global molecular cancer diagnostic devices market

PART 10: Market segmentation by cancer type
• Lung cancer
• Breast cancer
• Colorectal cancer
• Prostate cancer
• Cervical cancer

PART 11: Geographical segmentation
• Cancer diagnostic devices market in Americas
• Cancer diagnostic devices market in EMEA
• Cancer diagnostic devices market in APAC

PART 12: Market drivers
• Prevalence of cancer
• Need for cost-cutting in drug discovery and development
• Demand for personalized medicines
• Advances in technology
• Focus on emerging countries

PART 13: Impact of drivers

PART 14: Market challenges
• Unfavorable reimbursement scenario
• High cost of developing companion diagnostics
• Stringent regulatory framework
• Lack of skilled personnel

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Adoption of various strategies
• Increase in R&D
• Product approvals and launches

PART 17: Vendor landscape
• Competitive scenario
• Keys news
• M&A

PART 18: Key vendors
• Abbott Diagnostics
• Agilent Technologies
• BD
• bioMérieux
• Qiagen
• Roche Diagnostics
• Other prominent vendors

PART 19: Appendix
• List of abbreviations

PART 20: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Prevalent cancer types worldwide 2012
Exhibit 03: Top countries with highest cancer rate worldwide 2012
Exhibit 04: Cancer statistics by gender 2012
Exhibit 05: Global cancer diagnostic devices market 2015-2020 ($ billions)
Exhibit 06: Five forces analysis
Exhibit 07: Reimbursement perspectives of healthcare entities
Exhibit 08: Factors influencing cost of cancer diagnostic devices
Exhibit 09: Global cancer diagnostic devices market segmentation by product
Exhibit 10: Global companion cancer diagnostic devices market 2015-2020 ($ millions)
Exhibit 11: Global molecular cancer diagnostic devices market 2015-2020 ($ billions)
Exhibit 12: Global cancer diagnostic devices market segmentation by cancer type 2015
Exhibit 13: Cancer types and associated diagnosis methods
Exhibit 14: Global cancer diagnostic devices market segmentation by geography 2015
Exhibit 15: Global cancer diagnostic devices market segmentation by geography 2020
Exhibit 16: Global cancer diagnostic devices market segmentation by geography 2015-2020 ($ millions)
Exhibit 17: Global cancer diagnostic devices market segmentation by geography 2015-2020
Exhibit 18: Cancer diagnostic devices market in Americas 2015-2020 ($ billions)
Exhibit 19: Cancer diagnostic devices market in EMEA 2015-2020 ($ millions)
Exhibit 20: Cancer diagnostic devices market in APAC 2015-2020 ($ millions)
Exhibit 21: Impact of drivers
Exhibit 22: Impact of drivers and challenges
Exhibit 23: Abbott Diagnostics: Product portfolio
Exhibit 24: Abbott Diagnostics: Key takeaways
Exhibit 25: Agilent Technologies: Product portfolio
Exhibit 26: Agilent Technologies: Revenue of diagnostics and genomics segment 2013-2015 ($ millions)
Exhibit 27: Agilent Technologies: Key takeaways
Exhibit 28: BD: Product portfolio
Exhibit 29: BD: Revenue of life sciences segment 2013-2015 ($ billions)
Exhibit 30: BD: Key takeaways
Exhibit 31: bioMérieux: Product portfolio
Exhibit 32: bioMérieux: Key takeaways
Exhibit 33: Qiagen: Product portfolio
Exhibit 34: Qiagen: Revenue of consumable and related products 2013-2015 ($ billions)
Exhibit 35: Qiagen: Key takeaways
Exhibit 36: Roche Diagnostics: Product portfolio
Exhibit 37: Roche Diagnostics: Revenue of molecular diagnostics segment 2013-2015 ($ billions)
Exhibit 38: Roche Diagnostics: Key takeaways
Exhibit 39: Other prominent vendors


【レポート販売概要】

■ タイトル:癌診断装置の世界市場:肺癌、乳癌、大腸癌、前立腺癌、子宮頸癌
■ 英文:Global Cancer Diagnostics Device Market 2016-2020
■ 発行日:2016年6月13日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9265
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。